It's reported in The Age tonight that a 9 year old boy is in the Monash ICU in Melbourne suffering from a rare respiratory condition called PIMS-TS which is described as being similar to Kawasaki disease and is believed to be linked to COVID-19.
Taking into account that Monash just agreed to participate in the MSB Phase 3 trial it would be interesting to see if consideration is given to offer the young fella a remestemcel-L infusion?
banter and General Discussion, page-1248
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.255(16.7%) |
Mkt cap ! $2.032B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.83 | $1.71 | $27.76M | 15.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 48074 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |